Page last updated: 2024-12-10

gardenia yellow

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gardenia yellow: extract of gardenia fruit; RN given refers to cpd with unknown MF [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

crocin-1 : A diester that is crocetin in which both of the carboxy groups have been converted to their gentiobiosyl esters. It is one of the water-soluble yellow-red pigments of saffron and is used as a spice for flavouring and colouring food. Note that in India, the term 'Crocin' is also used by GlaxoSmithKline as a brand-name for paracetamol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
IndiagenusA country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi.[MeSH]OrchidaceaeA plant family of the order Asparagales. All members of the orchid family have the same bilaterally symmetrical flower structure, with three sepals, but the flowers vary greatly in color and shape.[MeSH]

Cross-References

ID SourceID
PubMed CID5281233
CHEMBL ID446785
CHEBI ID79068
SCHEMBL ID1463936
MeSH IDM0161192

Synonyms (69)

Synonym
94238-00-3
gardenia yellow
8,8'-diapo-psi,psi-carotenedioic acid, bis(6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl) ester
brn 6473367
bis(6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl) 8,8'-diapo-psi,psi-carotenedioate
saffron
beta-d-glucopyranose, 6-o-beta-d-glucopyranosyl-, 1,1'-((2e,4e,6e,8e,10e,12e,14e)-2,6,11,15-tetramethyl-2,4,6,8,10,12,14-hexadecaheptaenedioate)
einecs 255-881-6
crocetin bis(gentiobiosyl) ester
alpha-crocin
all-trans-crocetin di-beta-d-gentiobiosyl ester
ccris 678
crocin 1
ccris 7705
C08589
NCGC00160471-01
11012-59-2
bdbm50260195
crocin-1
.alpha.-crocin
crocetin di(beta-gentiobiosyl)ester
chebi:79068 ,
crocetin di-gentiobiose ester
CHEMBL446785 ,
bis[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] (2e,4e,6e,8e,10e,12e,14e)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate
tox21_111837
dtxsid7046172 ,
cas-42553-65-1
dtxcid201457
SCHEMBL1463936
unii-f32ba2h92z
f32ba2h92z ,
crocine
einecs 254-465-1
S9511 ,
crocin i
hsdb 8211
unii-877gwi46c2
877gwi46c2 ,
trans-crocetin di(beta-d-gentiobiosyl) ester
crocin a
AKOS015896765
crocin [who-dd]
crocin [inci]
trans-crocetin di(.beta.-d-gentiobiosyl) ester
.beta.-d-glucopyranose, 6-o-.beta.-d-glucopyranosyl-, 1,1'-((2e,4e,6e,8e,10e,12e,14e)-2,6,11,15-tetramethyl-2,4,6,8,10,12,14-hexadecaheptaenedioate)
crocetin di-gentiobiose ester [mi]
8,8'-diapo-.psi.,.psi.-carotenedioic acid, bis(6-o-.beta.-d-glucopyranosyl-.beta.-d-glucopyranosyl) ester
all-trans-crocetin di-.beta.-d-gentiobiosyl ester
crocetin digentiobioside
bis[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl]oxy}methyl)tetrahydro-2h-pyran-2-yl] (2e,4e,6e,8e,10e,12e,14e)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate
crocetin di-beta-d-gentiobiose ester
trans-crocetin bis(beta-d-gentiobiosyl) ester
c.i. 75100
natural red 1
natural yellow 19
bis(beta-d-gentiobiosyl) crocetin
crocin-i
bis(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (2e,4e,6e,8e,10e,12e,14e)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate
DB11874
Q424767
HY-N0697
HMS3887O07
NCGC00160471-02
(2e,4e,6e,8e,10e,12e,14e)-bis((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl) 2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate
CS-0009714
A872860
(2e,4e,6e,8e,10e,12e,14e)-bis((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate
FS-10544

Research Excerpts

Overview

"Gardenia yellow" is a natural food colorant which is extracted by ethanol from gardenia fruit. Gardenia yellow pigment (GYP) is a collection of compounds with shared structure of crocin.

ExcerptReferenceRelevance
"Gardenia yellow pigment (GYP) is a collection of compounds with shared structure of crocin, which confers antidepressant activity. "( Instant and Persistent Antidepressant Response of Gardenia Yellow Pigment Is Associated with Acute Protein Synthesis and Delayed Upregulation of BDNF Expression in the Hippocampus.
Cai, B; Chen, G; Doron, R; Tao, W; Wu, H; Wu, R; Xue, W; Zhang, H; Zou, Z, 2016
)
2.13
""Gardenia yellow" is a natural food colorant which is extracted by ethanol from gardenia fruit."( Genotoxicity of gardenia yellow and its components.
Endo, G; Furusawa, N; Kitano, M; Kuroda, K; Ozaki, A; Yamaguchi, H, 2002
)
1.28

Effects

Gardenia yellow has been used for food colorent, medicine, feedingstuff and cosmetic. Gardenia yellow pigment has also been widely used as an excellent natural dye-stuff.

ExcerptReferenceRelevance
"Gardenia yellow pigment has also been widely used as an excellent natural dye-stuff."( Gardenia jasminoides Ellis: Ethnopharmacology, phytochemistry, and pharmacological and industrial applications of an important traditional Chinese medicine.
Chen, L; Li, M; Li, X; Tao, W; Tian, X; Wang, P; Wang, W; Yang, Z, 2020
)
1.28
"Gardenia yellow pigment has been the most important source of a natural colourant for food, cloth and paint for thousands of years."( Gardenia jasminoides Ellis: Ethnopharmacology, phytochemistry, and pharmacological and industrial applications of an important traditional Chinese medicine.
Chen, L; Li, M; Li, X; Tao, W; Tian, X; Wang, P; Wang, W; Yang, Z, 2020
)
1.28
"Gardenia yellow has been used for food colorent, medicine, feedingstuff and cosmetic."( [Research and development of Fructus Gardeniae].
Fu, HZ; Ni, HY; Zhang, ZH, 2006
)
1.06

Toxicity

ExcerptReferenceRelevance
" Slightly increased plasma total bilirubin was considered to be due to interference of metabolite of geniposide with the system of measurement and not to be a toxic effect since there were no related changes in histopathology of the liver or in any blood chemistry parameters."( A 13-week oral dose subchronic toxicity study of gardenia yellow containing geniposide in rats.
Chino, M; Hiruma, M; Kitamura, H; Nomura, M; Sato, S; Takei, Y, 2007
)
0.59
"To explore the potential the adverse outcome pathway of Gardenia Yellow (GY)-induced sensitive endpoint for nephrotoxicity, an integrated strategy was applied in the present study."( Investigation on the potential adverse outcome pathway of the sensitive endpoint for nephrotoxicity induced by gardenia yellow based on an integrated strategy using bioinformatics analysis and in vitro testing validation.
Hao, LL; Liang, J; Ning, JY; Wei, HX; Zhang, L; Zhou, YY, 2023
)
1.37

Bioavailability

ExcerptReferenceRelevance
"An early prediction of solubility in physiological media (PBS, SGF and SIF) is useful to predict qualitatively bioavailability and absorption of lead candidates."( Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Bharate, SS; Vishwakarma, RA, 2015
)
0.42
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (10 Product(s))

Product Categories

Product CategoryProducts
Herbs, Botanicals & Homeopathy3
Household Essentials1
Vitamins & Supplements2
Beauty & Personal Care1
Food & Beverages3

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Bach Rescue Plus Mood & Stress Support Gummies Orange -- 60 GummiesBachHerbs, Botanicals & HomeopathyVitamin D3, GABA, Saffron2024-11-29 10:47:42
Clearly Natural Essentials Glycerin Liquid Hand Soap Orange -- 12 fl ozClearly NaturalHousehold Essentialsannatto, tocopherol, decyl glucoside, tocopherol, saffron, vitamin E, glycerin, phenoxyethanol2024-11-29 10:47:42
Force Factor AREDS 2+ Eye Health Formula Tropical Fruit -- 60 Soft ChewsForce FactorVitamins & SupplementsVitamin C, Vitamin E, Saffron, Vitamin E, Lutein, Zeaxanthin2024-11-29 10:47:42
Force Factor Complete Eye Health - Advanced Vitamin & Mineral Formula -- 60 Vegetable CapsulesForce FactorVitamins & SupplementsVitamin E, Saffron, Vitamin E, Lutein, Vitamin A, Zeaxanthin2024-11-29 10:47:42
Herbatint Chamomile Shampoo -- 8.79 fl ozHerbatintBeauty & Personal Carechamomile, cocamidopropyl betaine, saffron, imidazolidinyl urea, sodium benzoate2024-11-29 10:47:42
Source Naturals Serene ScienceĀ® Saffron Extract -- 60 TabletsSource NaturalsHerbs, Botanicals & HomeopathySaffron, microcrystalline cellulose, Sorbitol2024-11-29 10:47:42
Youtheory Saffron -- 60 CapsulesYoutheoryHerbs, Botanicals & HomeopathySaffron, microcrystalline cellulose, Ashwagandha2024-11-29 10:47:42
YumEarth Gummy Bears Non-GMO Favorite Fruits Assorted -- 10 Snack PacksYumEarthFood & Beveragescitric acid, annatto, Vitamin C, citric acid, saffron, Vitamin A2024-11-29 10:47:42
YumEarth Gummy Bears Non-GMO Favorite Fruits Assorted -- 5 Snack PacksYumEarthFood & Beveragescitric acid, Vitamin C, citric acid, saffron, Vitamin A2024-11-29 10:47:42
YumEarth Gummy Bears Non-GMO Favorite Fruits Assorted Fruit -- 15 PackYumEarthFood & Beveragescitric acid, ascorbic acid, citric acid, saffron2024-11-29 10:47:42

Roles (4)

RoleDescription
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
food colouringA food additive that imparts colour to food. In European countries, E-numbers for permitted food colours are from E 100 to E 199, divided into yellows (E 100-109), oranges (E 110-119), reds (E 120-129), blues and violets (E 130-139), greens (E 140-149), browns and blacks (E 150-159), and others (E 160-199).
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
histological dyeA dye used in microscopic or electron microscopic examination of cells and tissues to give contrast and to highlight particular features of interest, such as nuclei and cytoplasm.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
diesterA diester is a compound containing two ester groups.
disaccharide derivativeA carbohydrate derivative that is formally obtained from a disaccharide.
diterpenoidAny terpenoid derived from a diterpene. The term includes compounds in which the C20 skeleton of the parent diterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
crocetin esters biosynthesis39

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
USP1 protein, partialHomo sapiens (human)Potency100.00000.031637.5844354.8130AID504865
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency13.44810.000214.376460.0339AID720692
estrogen nuclear receptor alphaHomo sapiens (human)Potency30.14890.000229.305416,493.5996AID743075; AID743079
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency17.78280.035520.977089.1251AID504332
DNA polymerase kappa isoform 1Homo sapiens (human)Potency21.19230.031622.3146100.0000AID588579
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency0.00410.005612.367736.1254AID624032
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)140.00000.03403.987110.0000AID336442
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)170.00000.00002.37899.7700AID1158610
Amine oxidase [flavin-containing] BHomo sapiens (human)IC50 (µMol)128.00000.00001.89149.5700AID1158611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (15)

Processvia Protein(s)Taxonomy
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
response to xenobiotic stimulusAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceAmine oxidase [flavin-containing] BHomo sapiens (human)
response to aluminum ionAmine oxidase [flavin-containing] BHomo sapiens (human)
response to selenium ionAmine oxidase [flavin-containing] BHomo sapiens (human)
negative regulation of serotonin secretionAmine oxidase [flavin-containing] BHomo sapiens (human)
phenylethylamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
substantia nigra developmentAmine oxidase [flavin-containing] BHomo sapiens (human)
response to lipopolysaccharideAmine oxidase [flavin-containing] BHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to ethanolAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of dopamine metabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
hydrogen peroxide biosynthetic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to corticosteroneAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
electron transfer activityAmine oxidase [flavin-containing] BHomo sapiens (human)
identical protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial envelopeAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] BHomo sapiens (human)
dendriteAmine oxidase [flavin-containing] BHomo sapiens (human)
neuronal cell bodyAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (24)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1193496Thermodynamic equilibrium solubility, log S of the compound in water at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1193492Thermodynamic equilibrium solubility, log S of the compound in water at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1193498Thermodynamic equilibrium solubility, log S of the compound simulated gastric fluid at pH 1.2 at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1193499Thermodynamic equilibrium solubility, log S of the compound simulated intestinal fluid at pH 6.8 at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID725307Inhibition of nitric oxide production in lipopolysaccharide-activated mouse RAW264.7 cells by Griess reaction based method2013Bioorganic & medicinal chemistry letters, Feb-15, Volume: 23, Issue:4
Chemical constituents from the fruit of Gardenia jasminoides and their inhibitory effects on nitric oxide production.
AID1158610Inhibition of recombinant human MAO-A expressed in insect cells assessed as inhibition of oxidation of kynuramine to 4-hydroxyquinoline after 20 mins by fluorescence spectrophotometry2014European journal of medicinal chemistry, Jul-23, Volume: 82New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies.
AID735999Antiviral activity against EV71 infected in human RD cells assessed as cell survival rate at 1 to 2 mg/ml after 24 hrs by WST-1 assay2013European journal of medicinal chemistry, Apr, Volume: 62Inhibition of enterovirus 71 infections and viral IRES activity by Fructus gardeniae and geniposide.
AID1193493Thermodynamic equilibrium solubility, log S of the compound in PBS at pH 7.4 at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1193495Thermodynamic equilibrium solubility, log S of the compound in simulated intestinal fluid at pH 6.8 at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1872829Inhibition of CIS-induced TLR4 protein expression in rat hepatic tissue by Western blot analysis2022European journal of medicinal chemistry, May-05, Volume: 235Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective.
AID1158611Inhibition of recombinant human MAO-B expressed in insect cells assessed as inhibition of oxidation of kynuramine to 4-hydroxyquinoline after 20 mins by fluorescence spectrophotometry2014European journal of medicinal chemistry, Jul-23, Volume: 82New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies.
AID336442Inhibition of mushroom tyrosinase2002Journal of natural products, Oct, Volume: 65, Issue:10
Constituents of the stigmas of Crocus sativus and their tyrosinase inhibitory activity.
AID1193497Thermodynamic equilibrium solubility, log S of the compound PBS at pH 7.4 at RT after 24 hrs by shake-flask method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1872830Inhibition of CIS-induced MyD88 mRNA expression in rat hepatic tissue by SYBR-green dye based RT-PCR analysis2022European journal of medicinal chemistry, May-05, Volume: 235Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective.
AID1193494Thermodynamic equilibrium solubility, log S of the compound in simulated gastric fluid at pH 1.2 at RT after 4 hrs by 96 well plate method2015Bioorganic & medicinal chemistry letters, Apr-01, Volume: 25, Issue:7
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
AID1872828Inhibition of CIS-induced TLR4 mRNA expression in rat hepatic tissue by SYBR-green dye based RT-PCR analysis2022European journal of medicinal chemistry, May-05, Volume: 235Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective.
AID1872831Inhibition of CIS-induced NF-kappaBp53 mRNA expression in rat hepatic tissue by SYBR-green dye based RT-PCR analysis2022European journal of medicinal chemistry, May-05, Volume: 235Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.23)18.7374
1990's0 (0.00)18.2507
2000's5 (16.13)29.6817
2010's15 (48.39)24.3611
2020's10 (32.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 58.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index58.55 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index111.35 (26.88)
Search Engine Supply Index2.40 (0.95)

This Compound (58.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (9.68%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (90.32%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]